Chemed Price to Sales Ratio 2012-2026 | CHE
Historical PS ratio values for Chemed (CHE) over the last 10 years. The current P/S ratio for Chemed as of June 12, 2026 is .
| Chemed P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-06-15 | 423.49 | 2.36 | |
| 2026-03-31 | 377.22 | $179.12 | 2.11 |
| 2025-12-31 | 426.74 | $174.91 | 2.44 |
| 2025-09-30 | 445.95 | $171.42 | 2.60 |
| 2025-06-30 | 484.31 | $168.01 | 2.88 |
| 2025-03-31 | 611.48 | $165.00 | 3.71 |
| 2024-12-31 | 526.01 | $159.59 | 3.30 |
| 2024-09-30 | 596.14 | $156.00 | 3.82 |
| 2024-06-30 | 537.75 | $153.17 | 3.51 |
| 2024-03-31 | 635.75 | $150.49 | 4.22 |
| 2023-12-31 | 578.73 | $149.15 | 3.88 |
| 2023-09-30 | 514.00 | $146.81 | 3.50 |
| 2023-06-30 | 535.31 | $144.67 | 3.70 |
| 2023-03-31 | 531.06 | $143.44 | 3.70 |
| 2022-12-31 | 503.70 | $141.29 | 3.57 |
| 2022-09-30 | 430.47 | $139.02 | 3.10 |
| 2022-06-30 | 462.48 | $138.03 | 3.35 |
| 2022-03-31 | 498.73 | $135.93 | 3.67 |
| 2021-12-31 | 520.47 | $133.34 | 3.90 |
| 2021-09-30 | 457.25 | $131.91 | 3.47 |
| 2021-06-30 | 466.10 | $130.18 | 3.58 |
| 2021-03-31 | 451.37 | $127.79 | 3.53 |
| 2020-12-31 | 522.43 | $126.69 | 4.12 |
| 2020-09-30 | 470.84 | $125.77 | 3.74 |
| 2020-06-30 | 441.84 | $122.54 | 3.61 |
| 2020-03-31 | 424.05 | $120.66 | 3.51 |
| 2019-12-31 | 429.67 | $117.39 | 3.66 |
| 2019-09-30 | 408.14 | $113.01 | 3.61 |
| 2019-06-30 | 352.43 | $110.46 | 3.19 |
| 2019-03-31 | 312.32 | $107.95 | 2.89 |
| 2018-12-31 | 276.17 | $106.00 | 2.61 |
| 2018-09-30 | 311.27 | $104.36 | 2.98 |
| 2018-06-30 | 313.15 | $102.91 | 3.04 |
| 2018-03-31 | 265.29 | $102.55 | 2.59 |
| 2017-12-31 | 236.02 | $100.70 | 2.34 |
| 2017-09-30 | 195.99 | $99.15 | 1.98 |
| 2017-06-30 | 198.11 | $97.82 | 2.03 |
| 2017-03-31 | 176.73 | $95.09 | 1.86 |
| 2016-12-31 | 154.95 | $93.67 | 1.65 |
| 2016-09-30 | 136.01 | $92.52 | 1.47 |
| 2016-06-30 | 131.18 | $90.98 | 1.44 |
| 2016-03-31 | 130.11 | $89.71 | 1.45 |
| 2015-12-31 | 143.62 | $88.54 | 1.62 |
| 2015-09-30 | 127.76 | $86.93 | 1.47 |
| 2015-06-30 | 125.29 | $85.09 | 1.47 |
| 2015-03-31 | 113.90 | $83.31 | 1.37 |
| 2014-12-31 | 100.61 | $81.32 | 1.24 |
| 2014-09-30 | 97.78 | $78.81 | 1.24 |
| 2014-06-30 | 88.87 | $76.88 | 1.16 |
| 2014-03-31 | 84.63 | $75.57 | 1.12 |
| 2013-12-31 | 72.32 | $75.29 | 0.96 |
| 2013-09-30 | 67.31 | $75.59 | 0.89 |
| 2013-06-30 | 67.99 | $75.45 | 0.90 |
| 2013-03-31 | 74.88 | $74.90 | 1.00 |
| 2012-12-31 | 64.07 | $73.84 | 0.87 |
| 2012-09-30 | 64.54 | $71.51 | 0.90 |
| 2012-06-30 | 56.13 | $69.46 | 0.81 |
| 2012-03-31 | 58.05 | $66.58 | 0.87 |
| 2011-12-31 | 47.30 | $63.69 | 0.74 |
| 2011-09-30 | 50.62 | $61.57 | 0.82 |
| 2011-06-30 | 60.18 | $59.29 | 1.02 |
| 2011-03-31 | 61.05 | $57.53 | 1.06 |
| 2010-12-31 | 58.09 | $55.60 | 1.04 |
| 2010-09-30 | 51.98 | $54.33 | 0.96 |
| 2010-06-30 | 49.72 | $53.45 | 0.93 |
| 2010-03-31 | 49.38 | $52.82 | 0.93 |
| 2009-12-31 | 43.46 | $52.43 | 0.83 |
| 2009-09-30 | 39.67 | $51.60 | 0.77 |
| 2009-06-30 | 35.58 | $51.18 | 0.70 |
| 2009-03-31 | 35.01 | $50.08 | 0.70 |
| 2008-12-31 | 35.74 | $48.80 | 0.73 |
| 2008-09-30 | 36.84 | $47.69 | 0.77 |
| 2008-06-30 | 32.81 | $46.20 | 0.71 |
| 2008-03-31 | 37.75 | $45.10 | 0.84 |
| 2007-12-31 | 49.93 | $43.69 | 1.14 |
| 2007-09-30 | 55.48 | $42.49 | 1.31 |
| 2007-06-30 | 59.11 | $40.88 | 1.45 |
| 2007-03-31 | 43.62 | $39.34 | 1.11 |
| 2006-12-31 | 32.90 | $38.13 | 0.86 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $5.639B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |